By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Anika Therapeutics 

32 Wiggins Avenue

Bedford  Massachusetts  01730   U.S.A.
Phone: 781-457-9000 Fax: 781-935-4120


SEARCH JOBS
Anika Therapeutics is a pioneer in developing therapeutic products for tissue protection, healing and repair. These products are based on hyaluronic acid (HA), a naturally occurring polymer found throughout the body. HA enhances joint function and coats, protects, cushions and lubricates soft tissues. HA also is present in the skin, where it supports skin structure and elasticity. With more than 20 years of experience in HA technology, Anika is recognized worldwide as a provider of premium HA products that are effective, safe and long-lasting.

Anika manufactures and distributes a diverse portfolio of HA-based products that cover a broad range of therapeutic applications. These products include ORTHOVISC®, ORTHOVISC® mini, and MONOVISC™ used in the treatment of osteoarthritis; HYVISC® used in the treatment of equine osteoarthritis; the ELEVESS™ family of cosmetic dermatology products for facial wrinkles, scar remediation and lip augmentation; AMVISC®, AMVISC® Plus, STAARVISC™ II, and OPTIVISC™ injectable viscoelastic HA products for ophthalmic surgery; INCERT®, an HA-based anti-adhesive for surgical applications; and next-generation products for joint health and aesthetic dermatology based on the Company's proprietary, chemically modified HA.


Key Statistics


Email:
Ownership: Public

Web Site: Anika Therapeutics
Employees:
Symbol: ANIK
 



Industry
Biotechnology






Company News
Anika Therapeutics (ANIK) Announces U.S. Commercialization Partnership For Hyalomatrix® With Wound Care Leader Medline Industries, Inc. 7/30/2014 11:10:52 AM
Anika Therapeutics (ANIK) Announces Date Of Second-Quarter 2014 Financial Results Conference Call 7/16/2014 11:23:17 AM
Anika Therapeutics (ANIK) Reports First Quarter 2014 Financial Results 4/30/2014 8:07:33 AM
Anika Therapeutics (ANIK) Announces Date Of First-Quarter 2014 Financial Results Conference Call 4/17/2014 6:50:23 AM
Anika Therapeutics (ANIK) Announces First U.S. Commercial Sale Of Monovisc® 4/16/2014 9:23:07 AM
Anika Therapeutics (ANIK) Announces Dismissal Of MONOVISC® U.S. Patent Infringement Lawsuit 3/13/2014 8:01:23 AM
Anika Therapeutics (ANIK) To Present At Canaccord Genuity Musculoskeletal Conference March 11 3/5/2014 7:27:06 AM
Anika Therapeutics (ANIK) Reports Fourth Quarter And Full Year 2013 Financial Results 2/27/2014 7:10:52 AM
FDA Green Lights Anika Therapeutics (ANIK)'s Osteoarthritis Drug MONOVISC® Stock Surges +31.74% At 9:51AM ET On Wednesday 2/26/2014 7:00:57 AM
Anika Therapeutics (ANIK) Announces Date Of Fourth-Quarter And Year-End 2013 Financial Results Conference Call 2/13/2014 8:56:22 AM
12345678910...
//-->